Login to Your Account

Obesity Drug Drives Proxy Fight

Vivus Cozies Up to Menarini on ED Drug, but Whither Qsymia?

By Marie Powers
Staff Writer

Wednesday, July 10, 2013
After spending three months seeking to tamp down a proxy battle with shareholder First Manhattan Co. (FMC), Vivus Inc. got a bit of a lift Tuesday.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription